who invented glp-1 drugs Glucagon-like peptide-1

GLP 1 drugs are often framed as weight loss drugs, but that perspective overlooks their deeper biology. Randomized trials show meaningful effects on cardiovascular events, visceral fat, kidney health, and inflammation. Semaglutide already has Novo, Lilly buoyed by fast growing GLP 1 drug sales BioPharma Dive Metformin Modulates GLP 1 and GIP Mediated Intracellular Signaling under Normoglycemic Conditions Exploration of the potential association between GLP 1 receptor agonists and suicidal or self injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database BMC Medicine Springer Nature Glucagon like peptide 1 receptor agonists and muscle mass effects ScienceDirect